Fluidigm Announce Israeli Distribution Deal
News Mar 01, 2011
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm's complete portfolio of BioMark™, EP1™, and Access Array™ Systems and the complete line up of Dynamic Array™, Digital Array™ and Access Array IFCs for real-time PCR, digital PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing.
Eisenberg Brothers has a 50-year history in providing high end genetic analysis solutions to research organizations and businesses.
"This exciting partnership with Fluidigm will provide the scientific communities in Israel with powerful genomic tools backed by outstanding support," noted Amos Grundwag, Manager of the Genomics and Bio Informatics lines at Eisenberg Brothers. "We are happy to add Fluidigm to our portfolio of world leading suppliers. We recognize Fluidigm to be a great solution for a wide range of biological challenges that the scientific community is currently handling."
"Fluidigm is committed to bringing the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in Israel," said Dominique Remy-Renou, Vice President of European Sales and Support and General Manager of Fluidigm Europe BV.
Remy-Renou continued, "Eisenberg Brothers has built a reputation of addressing the needs of Israel's life sciences research community and we look forward to helping bring the tools needed to solve some of today's most complex genetic questions in biology all the way down to the single cell."
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018